Navigation Links
Ajinomoto Co., Inc. Agrees To Acquire Althea Technologies, Inc.
Date:3/6/2013

SAN DIEGO, March 6, 2013 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Althea Technologies, Inc. ("Althea Technologies"), announced today that they have entered into a definitive agreement by which Ajinomoto Co. will acquire Althea Technologies, a leading provider of biopharmaceutical development and manufacturing services, subject to the terms of the definitive agreement (including the satisfaction of customary closing conditions).

(Logo: http://photos.prnewswire.com/prnh/20121024/LA98976LOGO)

Under the terms of the merger agreement, Ajinomoto will acquire all of the capital stock in Althea Technologies. In connection with the transaction, Ajinomoto has committed to continuing to provide the highest quality services to Althea's customers.

"We are thrilled that the company we founded 15 years ago will have the opportunity to accelerate its growth under the leadership of a highly successful global company, such as Ajinomoto," stated Dr. Magda Marquet and Dr. François Ferré, Founders of Althea Technologies. "We are very pleased with the depth of Ajinomoto's commitment to our brand, our strong culture and the development of our employees."

"We welcome and are honored to have Ajinomoto as the new owner of Althea," stated Matt Mackowski , Chairman of Telegraph Hill Partners and Co-Chair of Althea. "They will be delighted, as we have been, to work with Althea's extraordinarily talented and capable team of professionals who have made a practice of exceeding customer expectations while building one of the world's best companies in biopharmaceutical contract manufacturing." 

"This is a great day for Althea, our employees, our customers and investors," commented Rick Hancock , President and CEO of Althea Technologies. "During the past several months, I have had the opportunity to get to know members of the Ajinomoto team and I am convinced that the combination of our two companies will yield outstanding synergistic benefits. Both companies are dedicated to the highest levels of quality and customer care."

"Ajinomoto is delighted and honored to have Althea, their talented management and employees join our group," commented Masatoshi Ito , President and CEO of Ajinomoto Co., Inc. "In combining Ajinomoto's experience in biotechnology, together with Althea's sophisticated technology, experienced personnel, and expertise in cGMP manufacturing, we aspire to expand our business for biopharmaceuticals manufacturing  in the U.S. market and  strengthen our advanced  biomedical businesses."

The transaction is expected to close in early April 2013 at which point Althea will become a fully consolidated subsidiary of Ajinomoto Co., Inc. William Blair & Company, LLC served as financial advisor and Cooley LLP served as legal advisor to Althea Technologies in this transaction.

About Ajinomoto Co.
Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JYP 1,197.3 billion (USD 15.1 billion) in fiscal 2011. For more about Ajinomoto Co. (TYO: 2802), visit www.ajinomoto.com.

About Althea Technologies
Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Althea Technologies offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea Technologies offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea Technologies' formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. For more information, visit www.altheatech.com


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
2. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
3. Sonendo Agrees To Terms For Up To $20 Million In Financing
4. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
5. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
6. Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
7. PRA Acquires ClinStar
8. Endexx Acquires Medical Marijuana Management Technology
9. Royalty Pharma Announces Proposal To Acquire Elan
10. DSI Renal Acquires New Smyrna Beach Artificial Kidney Center
11. Henry Schein Acquires The Maddox Practice Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017   Vitasome ® ... of nutritional supplements using its groundbreaking new liposome technology. ... percent of potency through digestion per Physician,s Desk ... solve the problem of nutritional waste and are scientifically ... during digestive processes Improve bioavailability with ...
(Date:2/27/2017)... A recent research report published by Grand View Research, Inc. ... reach a value of $55.8 billion by 2025. Earlier in 2016, ... legalized marijuana for medical uses. In 2016, states such as ... North Dakota , Ohio and ... medical applications such as chemotherapies and pain management. The growing number ...
(Date:2/27/2017)... , Feb 27, 2017 The ... by NATO for use at the security level RESTRICTED. The ... the NATO organization for the communication of classified information. ... Sectra and ... with an eavesdrop-secure smartphone solution. Sectra Tiger/R is developed by ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme ... Center for Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) ... has compiled into a single volume a compelling argument that the disease does exist ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley ... proud to announce an upgrade to the company's Yelp listing. Bay Area residents ... topics as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an extension of ... to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite ... globally recognised standard that sets out requirements for the technical competence of testing ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable ... entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
Breaking Medicine News(10 mins):